SEC Form 4 · accession 0001225208-19-002987
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
Feb 15, 2019
Accepted (ET)
Feb 19, 2019 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 15, 2019 | M | 3,039 | $7.41 | A | 243,207 | D | |
| Common StockF3,F2 | Feb 15, 2019 | M | 1,661 | $0.00 | A | 244,868 | D | |
| Common StockF2 | Feb 15, 2019 | F | 575 | $40.01 | D | 244,293 | D | |
| Common StockF2 | Feb 15, 2019 | S | 3,039 | $40.32 | D | 241,254 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF3,F4 | — | Feb 15, 2019 | M | 1,661 | D | — | Feb 15, 2023 | Common Stock | 1,661 | 6,644 | D |
| Stock Option (Right to Buy)F5 | $7.41 | Feb 15, 2019 | M | 3,039 | D | — | Feb 16, 2020 | Common Stock | 3,039 | 12,154 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- F5Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four annual increments beginning on February 16, 2011, the first anniversary of the grant.